General
Patients are more aware about their 'biorights' and demand to be compensated
 

Patients are more aware about their 'biorights' and demand to be compensated

Shared by:

 
The value of genetic data has caught the attention of the public amidst increasing drug costs, leading to a desire for compensation, a guarantee of useful medical information, or control over how their samples will be studied.
 
today.mims.com
 
22 Oct 2016 - General
 
This is an interesting room for discussion. Studying and profiteering from these tissue samples without the patients' consent is straight up larceny. I feel that we should demand that the biological samples be discarded. For every study, an informed consent should be provided to let participants understand its benefits. This is one of the most basic requirements in every research and now a company will bypass it just to generate revenues. For the MIMS community, what do you feel about this v...
 (Total 84 words)